Brain metastases in patients with breast cancer: New Horizons

Clinical Breast Cancer

Volumn 6, Issue 2, 2005, Pages 115-124

  Kirsch, David G ^a   Loeffler, Jay S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotherapy; Neurosurgical resection; Radiation therapy; Radiosurgery

Indexed keywords

ANGIOGENESIS INHIBITOR; BROXURIDINE; CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; FLUOROURACIL; GADOLINIUM TEXAPHYRIN; LONIDAMINE; METHOTREXATE; MISONIDAZOLE; NIMUSTINE; PREDNISONE; TEMOZOLOMIDE; TRASTUZUMAB;

BLOOD BRAIN BARRIER; BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SCREENING; CLINICAL FEATURE; CLINICAL TRIAL; DATA ANALYSIS; DRUG DISTRIBUTION; DRUG PENETRATION; EVIDENCE BASED MEDICINE; GAMMA KNIFE RADIOSURGERY; GENE OVEREXPRESSION; HUMAN; MEDICAL DECISION MAKING; NEUROSURGERY; PREVALENCE; RADIOSURGERY; RETROSPECTIVE STUDY; REVIEW;

EID: 22144438674     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2005.n.013     Document Type: Review

References (49)

1. Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 1983; 23:175-180.
2. Tsukada Y, Fouad A, Pickren JW, et al. Central nervous system metastases from breast carcinoma. Autopsy study. Cancer 1983; 52:2349-2354.
3. Mahmoud-Ahmed AS, Suh JH, Lee SY, et al. Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. Int J Radiat Oncol Biol Phys 2002; 54:810-817.
4. Lentzsch S, Reichardt P, Weber F, et al. Brain metastases in breast cancer: prognostic factors and management. Eur J Cancer 1999;35:580-585.
5. DiStefano A, Yong Yap HY, Hortobagyi GN, et al. The natural history of breast cancer patients with brain metastases. Cancer 1979; 44:1913-1918.
6. Schouten L, Rutten J, Huveneers HA, et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002; 94:2698-2705.
7. Freilich RJ, Seidman AD, DeAngelis LM. Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer 1995; 76:232-236.
8. Miller KD, Weathers T, Haney LG, et al. Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on survival. Ann Oncol 2003;14:1072-1077.
9. Crivellari D, Pagani O, Veronesi A, et al. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol 2001; 12:353-356.
10. Bendell JC, Domchek SM, Burstein HJ, et al. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 2003; 97:2972-2977.
11. Mizutani Y, Yamashita T, Sakamoto G. Radiation therapy for brain metastases from breast cancer by histological classification. Nippon Igaku Hoshasen Gakkai Zasshi 2001; 61:89-95.
12. Fokstuen T, Wilking N, Rutqvist LE, et al. Radiation therapy in the management of brain metastases from breast cancer. Breast Cancer Res and Treat 2000; 62:211-216.
13. Wronski M, Arbit E, McCormick B. Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer 1997; 80:1746-1754.
14. Pieper DR, Hess KR, Sawaya RE. Role of surgery in the treatment of brain metastases in patients with breast cancer. Ann Surg Oncol 1997; 4:481-490.
15. Firlik KS, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for brain metastases from breast cancer. Ann Surg Oncol 2000; 7:333-338.
16. Amendola BE, Wolf AL, Coy SR, et al. Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast. Cancer J 2000; 6:88-92.
17. Lederman G, Wronski M, Fine M. Fractionated radiosurgery for brain metastases in 43 patients with breast carcinoma. Breast Cancer Res Treat 2001; 65:145-154.
18. Rosner D, Nemoto T, Lane WW. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 1986; 58:832-839.
19. Boogerd W, Dalesio O, Bais EM, et al. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 1992; 69:972-980.
20. Franciosi V, Cocconi G, Michiara M, et al. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Cancer 1999; 85:1599-1605.
21. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Eng J Med 1990; 322:494-500.
22. Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al. The choice of treatment of a single brain metastasis should be based on extracranial tumor activity and age. Int J Radia Oncol Biol Phys 1994; 29:711-717.
23. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in adddition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996; 78:1470-1476.
24. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37:745-751.
25. Bindal AK, Bindal RK, Hess KR, et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 1996; 84:748-754.
26. Alexander E 3rd, Moriarty TM, Davis RB, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995; 87:34-40.
27. Auchter RM, Lamond JP, Alexander E, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996; 35:27-35.
28. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363:1665-1672.
29. Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 1999; 43:549-558.
30. Hasegawa T, Kondziolka D, Flickinger JC, et al. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 2003; 52:1318-1326.
31. Sneed P, Suh J, Goetsch S, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002; 53:519-526.
32. DeAngelis L, Delattre J, Posner J. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989; 39:789-796.
33. Patchell RA, Tibbs PA, Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998; 280:1485-1489.
34. Sanghavi SN, Miranpuri SS, Chappell R, et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001; 51:426-434.
35. Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999; 45:427-434.
36. Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg 1993; 79:210-216.
37. Varlotto JM, Flickinger JC, Niranjan A, et al. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2003; 57:452-464.
38. Komarnicky LT, Phillips TL, Martz K, et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991; 20:53-58.
39. DeAngelis LM, Currie VE, Kim JH, et al. The combined use of radiation therapy and lonidamine in the treatment of brain metastases. J Neurooncol 1989; 7:241-247.
40. Phillips TL, Scott CB, Leibel SA, et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 1995; 33:339-348.
41. Ushio Y, Arita N, Hayakawa T, et al. Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. Neurosurgery 1991; 28:201-205.
42. Antonadou D, Paraskevaidis M, Sarris G, et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002; 20:3644-3650.
43. Abrey LE, Olson JD, Raizer JJ, et al. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 2001; 53:259-265.
44. Meyers CA, Smith JA, Bezjak A. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004; 22:157-165.
45. Lower EE, Drosick DR, Blau R, et al. Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival. Clin Breast Cancer 2003; 4:114-119.
46. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177-182.
47. Slamon D, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 from metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344:783-792.
48. Auperin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341:476-484.
49. Kirsch DG, Hochberg FH. Targeting HER2 in brain metastases from breast cancer. Clin Cancer Res 2003; 9:9435-9436.